HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laura Pike Selected Research

Laura Pike Research Topics

Disease

2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2013 - 09/2012
1Neoplasms (Cancer)
01/2020
1Anaplastic Thyroid Carcinoma
01/2018
1Thyroid Neoplasms (Thyroid Cancer)
05/2015
1Febrile Neutropenia
07/2013
1Stomatitis
07/2013
1Colorectal Neoplasms (Colorectal Cancer)
10/2012
1Dysphonia (Spastic Dysphonia)
03/2012
1Renal Cell Carcinoma (Grawitz Tumor)
03/2012
1Hypertension (High Blood Pressure)
03/2012
1Fatigue
03/2012

Drug/Important Bio-Agent (IBA)

22- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA
07/2013 - 09/2012
2Aurora Kinase BIBA
07/2013 - 09/2012
2cediranib (AZD2171)IBA
10/2012 - 03/2012
1Pharmaceutical PreparationsIBA
01/2020
1Bexarotene (LGD1069)FDA Link
05/2015
1Cytarabine (Cytosar-U)FDA LinkGeneric
07/2013
1Fluorouracil (Carac)FDA LinkGeneric
10/2012
1Capecitabine (Xeloda)FDA Link
10/2012
1Leucovorin (Folinic Acid)FDA Link
10/2012
1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2012
1Bevacizumab (Avastin)FDA Link
10/2012
1ProdrugsIBA
09/2012
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
09/2012
1AZD 1152-HQPAIBA
09/2012
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2012

Therapy/Procedure

1Therapeutics
01/2018
1Radiotherapy
01/2018
1Drug Therapy (Chemotherapy)
10/2012